Literature DB >> 10683187

Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.

L Brawley1, A M Shaw, A MacDonald.   

Abstract

beta-adrenoceptor-mediated relaxation was investigated in ring preparations of rat isolated thoracic aorta. Rings were pre-constricted with a sub-maximal concentration of noradrenaline (1 microM) and relaxant responses to cumulative concentrations of beta-adrenoceptor agonists obtained. The concentration-response curve (CRC) to isoprenaline was shifted to the right by propranolol (0.3 microM) with a steepening of the slope. Estimation of the magnitude of the shift from EC(50) values gave a pA(2) of 7.6. Selective beta(1)- and beta(2)-adrenoceptor antagonists, CGP 20712A (0.1 microM) and ICI 118551 (0.1 microM), respectively, produced 4 and 14 fold shifts of the isoprenaline CRC. Atypical beta-adrenoceptor agonists also produced concentration-dependent relaxation of aortic rings. The order of potency of the beta-adrenoceptor agonists was (-log EC(50)): isoprenaline (6. 25)>cyanopindolol (5.59)>isoprenaline+propranolol (5.11)>CGP 12177A (4.40)>ZD 2079 (4.24)>ZM 215001 (4.07)>BRL 37344 (3.89). Relaxation to CGP 12177A and ZM 215001 was unaffected by propranolol (0.3 microM). SR 59230A (</=1 microM) and cyanopindolol (1 microM), beta(3)-adrenoceptor antagonists, had no effect on the isoprenaline (in the presence of propranolol) or CGP 12177A CRCs. Bupranolol and CGP 20712A, at microM concentrations (beta(4)-adrenceptor antagonists), inhibited responses to isoprenaline (in the presence of propranolol) and CGP 12177A. In conclusion, atypical beta-adrenoceptors co-exist with beta(1)- and beta(2)-adrenoceptors in rat aorta. Although non-conventional partial agonists and selective beta(3)-adrenoceptor agonist cause relaxation, the vascular atypical beta-adrenoceptor does not appear to correspond to the beta(3)-adrenoceptor. There are, however, similarities with the putative beta(4)-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683187      PMCID: PMC1571885          DOI: 10.1038/sj.bjp.0703091

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  The beta-adrenergic radioligand [3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue.

Authors:  N Mohell; A Dicker
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

2.  Beta-adrenoceptors on endothelial cells do not influence release of relaxing factor in dog coronary arteries.

Authors:  P S Macdonald; P N Dubbin; G J Dusting
Journal:  Clin Exp Pharmacol Physiol       Date:  1987-06       Impact factor: 2.557

3.  Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs.

Authors:  J R Arch; A T Ainsworth; M A Cawthorne; V Piercy; M V Sennitt; V E Thody; C Wilson; S Wilson
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

4.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

5.  Effects of propranolol and L-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery.

Authors:  A MacDonald; M McLean; L MacAulay; A M Shaw
Journal:  J Auton Pharmacol       Date:  1999-06

6.  (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.

Authors:  G Engel; D Hoyer; R Berthold; H Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

7.  Beta-1 and beta-2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats.

Authors:  S R O'Donnell; J C Wanstall
Journal:  J Pharmacol Exp Ther       Date:  1984-03       Impact factor: 4.030

8.  The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists.

Authors:  C Wilson; S Wilson; V Piercy; M V Sennitt; J R Arch
Journal:  Eur J Pharmacol       Date:  1984-05-04       Impact factor: 4.432

9.  CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells.

Authors:  M Staehelin; P Simons; K Jaeggi; N Wigger
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

10.  Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations.

Authors:  S R O'Donnell; J C Wanstall
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

View more
  24 in total

1.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats.

Authors:  Agnieszka Zakrzeska; Eberhard Schlicker; Grzegorz Kwolek; Hanna Kozłowska; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 3.  The impact of GPCR structures on pharmacology and structure-based drug design.

Authors:  Miles Congreve; Fiona Marshall
Journal:  Br J Pharmacol       Date:  2009-11-13       Impact factor: 8.739

4.  beta-adrenoceptor mediated responses in rat pulmonary artery: putative role of TASK-1 related K channels.

Authors:  Detlef Bieger; Kakoli Parai; Carol Ann Ford; Reza Tabrizchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-25       Impact factor: 3.000

5.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

6.  Challenges in β(3)-Adrenoceptor Agonist Drug Development.

Authors:  Jonathan R S Arch
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

7.  Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.

Authors:  Fabrice Pourageaud; Véronique Leblais; Nadège Bellance; Roger Marthan; Bernard Muller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-26       Impact factor: 3.000

8.  Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.

Authors:  Albert Ferro; Marcy Coash; Takahiro Yamamoto; Jubli Rob; Yong Ji; Lindsay Queen
Journal:  Br J Pharmacol       Date:  2004-09-06       Impact factor: 8.739

9.  Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels.

Authors:  N Flacco; V Segura; M Perez-Aso; S Estrada; J F Seller; F Jiménez-Altayó; M A Noguera; P D'Ocon; E Vila; M D Ivorra
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 10.  Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling.

Authors:  Erika B Westcott; Steven S Segal
Journal:  Microcirculation       Date:  2013-04       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.